To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene F2RL1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
123 supporting clones for gene F2RL1 back to top
cDNA accession
Links to the sequence		 Tissue

most 5' clones
in red		 Match
mRNA		 From bp
to bp
in mRNA		 From bp
to bp
in accs.		 Clone encodes
complete protein
(with AA variation)		 Features Anomalies
detected by
AceView		 Accession
match over
(% length)		 Base differences
relative to genome
(% identity)
DB463838 hippocampus .a 1 to 367 1 to 408   tiling clone,   408/409
(99 %)		 3 diff
(99.3 %id)
DN997783 breast cancer, Mammary gland (cancer tissue) .a 28 to 777 1 to 789       789/789
(100 %)		 9 diff
(98.9 %id)
BX100183 Kidney .a 52 to 486 1 to 476       476/476
(100 %)		 4 diff
(99.2 %id)
BC018130 Pancreas, epithelioid carcinoma .a 53 to 2872 1 to 2861 T197S tiling clone, available from MGC, AAA   2861/2861
(100 %)		 3 diff
(99.9 %id)
U34038 Kidney .a 60 to 1466 1 to 1448 G44A     1448/1451
(99 %)		 9 diff
(99.4 %id)
BI765852 pooled colon, kidney, stomach .a 63 to 759 8 to 745       738/745
(99 %)		 8 diff
(99.0 %id)
TI_45235527   .a 63 to 705 61 to 744       684/746
(91 %)		 17 diff
(97.8 %id)
TI_57148752   .a 63 to 759 8 to 745       738/745
(99 %)		 8 diff
(99.0 %id)
BX417697 placenta .a 64 to 1089 1 to 1053       1053/1053
(100 %)		 21 diff
(98.1 %id)
BI517317 pooled colon, kidney, stomach .a 72 to 705 1 to 676       676/678
(99 %)		 8 diff
(98.9 %id)
BE621074 epithelioid carcinoma, Pancreas .a 73 to 605 1 to 587       587/1069
(54 %)		 20 diff
(98.2 %id)
CN311481 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 74 to 320 1 to 247       247/247
(100 %)		 7 diff
(97.2 %id)
CN311487 embryonic stem cells, cell lines H1, H7, andH9 .a 75 to 647 1 to 614       614/614
(100 %)		 2 diff
(99.7 %id)
BF568575 epithelioid carcinoma cell line, Pancreas .a 78 to 818 1 to 813       619/1028
(60 %)		 35 diff
(96.6 %id)
AA232603 brain, neuroepithelial cells .a 84 to 344 1 to 302       302/303
(99 %)		 10 diff
(96.7 %id)
CD654167 Embryonic Stem cells .a 86 to 860 1 to 817       817/817
(100 %)		 14 diff
(98.3 %id)
CN311489 embryonic stem cells, cell lines H1, H7, andH9 .a 89 to 715 1 to 668       668/668
(100 %)		 2 diff
(99.8 %id)
CN311482 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 91 to 436 1 to 387       387/387
(100 %)		 3 diff
(99.3 %id)
BC012453 Ovary, adenocarcinoma .a 115 to 2872 1 to 2803 exact available from MGC, AAA   2803/2803
(100 %)		 6 diff
(99.8 %id)
AY336105   .a 126 to 1359 1 to 1275 exact     1275/1275
(100 %)		 3 diff
(99.8 %id)
BF036025 adenocarcinoma, ovary .a 135 to 823 1 to 740       740/924
(80 %)		 63 diff
(93.2 %id)
CN311485 embryonic stem cells, cell lines H1, H7, andH9 .a 159 to 469 1 to 352       352/352
(100 %)		 4 diff
(98.9 %id)
BT009856   .a 207 to 1357 1 to 1192       1192/1194
(99 %)		 3 diff
(99.8 %id)
CV023209 mixed .a 207 to 785 1 to 620       620/620
(100 %)		 1 diff
(99.9 %id)
CV023588 mixed .a 207 to 820 1 to 653       653/654
(99 %)		 5 diff
(99.3 %id)
TI_1948076960   .a 207 to 733 133 to 692   fully sequenced,   560/692
(80 %)		 7 diff
(99.0 %id)
TI_1948077126   .a 207 to 711 131 to 682   fully sequenced,   552/682
(80 %)		 7 diff
(99.0 %id)
TI_1948077299   .a 207 to 743 133 to 704   fully sequenced,   572/704
(81 %)		 7 diff
(99.1 %id)
TI_1948077469   .a 207 to 709 135 to 679   fully sequenced,   545/679
(80 %)		 9 diff
(98.7 %id)
TI_1948126097   .a 207 to 910 136 to 886   fully sequenced,   751/886
(84 %)		 10 diff
(98.9 %id)
TI_1948126245   .a 207 to 869 138 to 857   fully sequenced,   720/857
(84 %)		 8 diff
(99.1 %id)
TI_1948126403   .a 207 to 887 153 to 882   fully sequenced,   730/834
(87 %)		 9 diff
(99.0 %id)
TI_1948126545   .a 207 to 778 137 to 756   fully sequenced,   620/756
(82 %)		 7 diff
(99.1 %id)
BE005953 breast_normal .a 233 to 900 1 to 665   tiling clone,   665/668
(99 %)		 16 diff
(97.7 %id)
BE005956 breast_normal .a 237 to 888 6 to 663       658/663
(99 %)		 23 diff
(96.6 %id)
CN311497 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 514 to 641 1 to 128       128/128
(100 %)		 0 diff
(100 %id)
DA543645   .a 653 to 1204 2 to 553   capped   552/552
(100 %)		 2 diff
(99.7 %id)
TI_1948077470   .a 679 to 1363 802 to 119   fully sequenced,   684/802
(85 %)		 7 diff
(99.2 %id)
TI_1948077127   .a 681 to 1363 804 to 123   fully sequenced,   682/804
(84 %)		 7 diff
(99.2 %id)
TI_1948076961   .a 703 to 1363 771 to 122   fully sequenced,   650/771
(84 %)		 7 diff
(99.1 %id)
TI_1948077300   .a 713 to 1363 771 to 125   fully sequenced,   647/771
(83 %)		 7 diff
(99.1 %id)
CN311490 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 716 to 1451 1 to 736       736/738
(99 %)		 3 diff
(99.6 %id)
CX783660 human embryonic stem cells .a 734 to 1455 1 to 722       722/722
(100 %)		 1 diff
(99.9 %id)
TI_1948126546   .a 748 to 1363 743 to 117   fully sequenced,   627/743
(84 %)		 8 diff
(99.0 %id)
TI_1948126246   .a 839 to 1363 655 to 120   fully sequenced,   536/655
(81 %)		 5 diff
(99.3 %id)
TI_1948126404   .a 857 to 1363 632 to 117   fully sequenced,   516/632
(81 %)		 5 diff
(99.3 %id)
TI_1948126098   .a 880 to 1363 612 to 118   fully sequenced,   495/612
(80 %)		 5 diff
(99.2 %id)
BG954726 colon .a 891 to 1222 1 to 336       336/338
(99 %)		 11 diff
(96.8 %id)
AW362651 colon .a 938 to 1216 290 to 11       280/291
(96 %)		 0 diff
(100 %id)
AW630645 2 pooled high-grade transitional celltumors, genitourinary tract .a 963 to 1356 1 to 394       394/394
(100 %)		 3 diff
(99.3 %id)
BG284622 adenocarcinoma, cell line, Prostate .a 1040 to 1777 1 to 733       733/733
(100 %)		 6 diff
(99.2 %id)
BU194105 bone marrow, from acute myelogenous leukemia .a 1054 to 1827 1 to 775       775/780
(99 %)		 6 diff
(99.3 %id)
BU156938 epithelioid carcinoma, Pancreas .a 1095 to 1839 1 to 753       753/780
(96 %)		 12 diff
(98.5 %id)
CN311486 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1096 to 1800 1 to 709       709/709
(100 %)		 7 diff
(99.1 %id)
CV347321 colon_normal .a 1101 to 1370 306 to 30     Submitted on the opposite strand 277/337
(82 %)		 0 diff
(100 %id)
CN311495 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1225 to 1991 5 to 771       767/771
(99 %)		 6 diff
(99.3 %id)
BF701739 brain, primitive neuroectoderm .a 1295 to 1359 266 to 332       296/332
(89 %)		 13 diff
(96.1 %id)
CR744738 ovarian tumor, ovary .a 1338 to 2046 1 to 713       713/713
(100 %)		 2 diff
(99.8 %id)
AA480816 ovarian tumor, ovary .a 1338 to 1827 1 to 493       493/493
(100 %)		 3 diff
(99.4 %id)
CN311492 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1357 to 2055 9 to 711       703/711
(98 %)		 6 diff
(99.2 %id)
BG167767 hypernephroma, cell line, Kidney .a 1435 to 2186 1 to 751       751/769
(97 %)		 7 diff
(99.1 %id)
U67058   .a 1441 to 2785 1 to 1348       1348/1349
(99 %)		 11 diff
(99.2 %id)
CX762707 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 1464 to 2142 1 to 674     Submitted on the opposite strand 674/845
(79 %)		 14 diff
(98.4 %id)
CN311483 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1489 to 2138 1 to 650       650/650
(100 %)		 0 diff
(100 %id)
AA373375 lung .a 1503 to 1815 1 to 314       314/314
(100 %)		 1 diff
(99.7 %id)
AW376169 colon .a 1640 to 1955 321 to 1       321/321
(100 %)		 5 diff
(98.5 %id)
BF696684 brain, primitive neuroectoderm .a 1710 to 2349 1 to 632       632/831
(76 %)		 21 diff
(97.5 %id)
BU945133 mixed (pool of 40 RNAs) .a 1767 to 2568 1 to 812       812/846
(95 %)		 32 diff
(96.3 %id)
AW380092 head_neck .a 1844 to 1955 18 to 129       112/129
(86 %)		 8 diff
(93.8 %id)
CN311493 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1848 to 2233 1 to 385       385/385
(100 %)		 1 diff
(99.8 %id)
BF669415 brain, primitive neuroectoderm .a 1885 to 2604 2 to 706       705/877
(80 %)		 25 diff
(97.2 %id)
BF035692 adenocarcinoma, ovary .a 1887 to 2638 1 to 745       745/928
(80 %)		 12 diff
(98.8 %id)
BM769473 stomach .a 1956 to 2552 1 to 597       597/597
(100 %)		 0 diff
(100 %id)
BM823562 stomach .a 1956 to 2482 1 to 527       527/527
(100 %)		 19 diff
(96.4 %id)
BM825681 stomach .a 1956 to 2443 1 to 488       488/488
(100 %)		 1 diff
(99.8 %id)
BM831086 stomach .a 1956 to 2506 1 to 551       551/551
(100 %)		 0 diff
(100 %id)
BF696245 brain, primitive neuroectoderm .a 1960 to 2678 1 to 719       719/824
(87 %)		 25 diff
(97.0 %id)
BF696455 brain, primitive neuroectoderm .a 1960 to 2640 1 to 681       681/797
(85 %)		 26 diff
(96.8 %id)
BF698010 brain, primitive neuroectoderm .a 1976 to 2648 1 to 671       671/795
(84 %)		 15 diff
(98.2 %id)
BM823534 stomach .a 2007 to 2446 1 to 440       440/440
(100 %)		 15 diff
(96.6 %id)
BF698465 brain, primitive neuroectoderm .a 2029 to 2791 1 to 755       755/815
(92 %)		 34 diff
(95.9 %id)
BI517938 pooled colon, kidney, stomach .a 2063 to 2793 781 to 24       758/781
(97 %)		 0 diff
(100 %id)
TI_45235528   .a 2063 to 2793 781 to 24       758/781
(97 %)		 0 diff
(100 %id)
CN311496 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2069 to 2832 1 to 763       763/767
(99 %)		 4 diff
(99.5 %id)
AW578908 colon .a 2084 to 2516 433 to 3       431/433
(99 %)		 0 diff
(100 %id)
AW861559 colon .a 2084 to 2520 439 to 1       439/439
(100 %)		 11 diff
(97.5 %id)
AV748015 Pituitary .a 2133 to 2677 1 to 534       534/537
(99 %)		 12 diff
(97.8 %id)
AV747417 Pituitary .a 2134 to 2684 1 to 540       540/546
(98 %)		 16 diff
(97.1 %id)
BE965369 epithelioid carcinoma, Pancreas .a 2160 to 2872 734 to 15   AAA   720/864
(83 %)		 49 diff
(94.4 %id)
BF696211 brain, primitive neuroectoderm .a 2169 to 2732 104 to 658       555/831
(66 %)		 24 diff
(97.2 %id)
AI478636 Kidney .a 2181 to 2502 322 to 1       322/322
(100 %)		 0 diff
(100 %id)
CA311036 Human Lung Epithelial cells, lung .a 2185 to 2872 706 to 19   AAA   688/688
(100 %)		 0 diff
(100 %id)
AA456265 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2197 to 2672 1 to 476   fully sequenced,   476/476
(100 %)		 1 diff
(99.8 %id)
R73284 breast .a 2212 to 2579 1 to 374       374/473
(79 %)		 8 diff
(98.4 %id)
AV719149 corresponding non cancerous liver tissue .a 2238 to 2867 630 to 1     Submitted on the opposite strand 630/630
(100 %)		 14 diff
(97.8 %id)
AA349223 adrenal gland .a 2274 to 2604 1 to 332       332/332
(100 %)		 1 diff
(99.7 %id)
BG577432   .a 2290 to 2782 1 to 491       491/491
(100 %)		 3 diff
(99.4 %id)
BQ020409 Fibrosarcoma .a 2331 to 2872 560 to 19   AAA   542/542
(100 %)		 0 diff
(100 %id)
AA304396 aorta .a 2350 to 2643 1 to 294       294/294
(100 %)		 0 diff
(100 %id)
BQ438864 epithelioid carcinoma, Pancreas .a 2366 to 2872 544 to 38   AAA Submitted on the opposite strand 507/858
(59 %)		 3 diff
(99.7 %id)
AI031794 parathyroid gland, parathyroid tumor .a 2401 to 2872 483 to 12   AAA   472/472
(100 %)		 0 diff
(100 %id)
AW615093 2 pooled high-grade transitional celltumors, genitourinary tract .a 2423 to 2869 454 to 8       447/454
(98 %)		 0 diff
(100 %id)
AW168623 bowel (skin primary), metastatic melanoma to bowel .a 2424 to 2868 448 to 1       448/448
(100 %)		 4 diff
(99.2 %id)
DB529897 hippocampus .a 2443 to 2870 1 to 429     Submitted on the opposite strand 429/430
(99 %)		 6 diff
(98.7 %id)
BE048381 Kidney .a 2446 to 2873 430 to 4       427/430
(99 %)		 0 diff
(100 %id)
AI921544 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2450 to 2873 428 to 5       424/428
(99 %)		 0 diff
(100 %id)
AI474121 colon, moderately-differentiated adenocarcinoma .a 2452 to 2873 422 to 1       422/422
(100 %)		 0 diff
(100 %id)
AW572517 adenocarcinoma, Pancreas .a 2457 to 2873 417 to 1       417/417
(100 %)		 0 diff
(100 %id)
AA514782 colon .a 2458 to 2873 419 to 4       416/419
(99 %)		 0 diff
(100 %id)
AI623157 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2475 to 2873 399 to 1       399/399
(100 %)		 0 diff
(100 %id)
AI554527 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2476 to 2872 397 to 1       397/397
(100 %)		 0 diff
(100 %id)
AW168625 bowel (skin primary), metastatic melanoma to bowel .a 2482 to 2868 387 to 1       387/387
(100 %)		 0 diff
(100 %id)
AA457706 ovarian tumor, ovary .a 2486 to 2872 387 to 1       387/387
(100 %)		 0 diff
(100 %id)
AI468671 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2493 to 2872 380 to 1       380/380
(100 %)		 5 diff
(98.7 %id)
AA232485 brain, neuroepithelial cells .a 2506 to 2872 367 to 1       367/367
(100 %)		 0 diff
(100 %id)
CK904231 Islets of Langerhans, Pancreas .a 2513 to 2872 1 to 360   AAA   360/360
(100 %)		 0 diff
(100 %id)
BM021348 Islets of Langerhans, Pancreas .a 2529 to 2873 1 to 345       345/352
(98 %)		 1 diff
(99.8 %id)
AI802498 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2571 to 2873 303 to 1       303/303
(100 %)		 0 diff
(100 %id)
AI758103 Kidney .a 2571 to 2872 302 to 1       302/302
(100 %)		 2 diff
(99.4 %id)
AI933567 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2575 to 2872 298 to 1       298/298
(100 %)		 2 diff
(99.4 %id)
R72830 breast .a 2592 to 2861 270 to 1       270/270
(100 %)		 0 diff
(100 %id)
AW272877 colon, moderately-differentiated adenocarcinoma .a 2606 to 2873 272 to 5       268/272
(98 %)		 0 diff
(100 %id)
AI470656 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2630 to 2867 265 to 28   AAA   238/249
(95 %)		 4 diff
(98.4 %id)
AA454652 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2642 to 2873 232 to 1   fully sequenced,   232/232
(100 %)		 1 diff
(99.6 %id)
AI023006 parathyroid gland, parathyroid tumor .a 2656 to 2872 234 to 18   AAA   217/217
(100 %)		 0 diff
(100 %id)
AI027174 parathyroid gland, parathyroid tumor .a 2657 to 2872 227 to 12   AAA   216/216
(100 %)		 0 diff
(100 %id)
AW079501 colon, moderately differentiated adenocarcinoma .a 2670 to 2873 204 to 1       204/204
(100 %)		 0 diff
(100 %id)
AI701234 adenocarcinoma, Pancreas .a 2725 to 2873 149 to 1       149/149
(100 %)		 0 diff
(100 %id)
CK904230 Islets of Langerhans, Pancreas .a 2726 to 2873 151 to 4       148/151
(98 %)		 0 diff
(100 %id)
AW578520 colon Gene F2RL1, variant not shown              
BQ310939 breast_normal Gene F2RL1, variant not shown              
CN311484 embryonic stem cells, cell lines H1, H7, andH9 Gene F2RL1, variant not shown              
CN311488 embryonic stem cells, cell lines H1, H7, andH9 Gene F2RL1, variant not shown         This clone was ignored    
CN311491 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene F2RL1, variant not shown              
CN311494 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 Gene F2RL1, variant not shown              
AI942392 Kidney Gene F2RL1, variant not shown              
BQ230613 epithelioid carcinoma, Pancreas Gene F2RL1, variant not shown         Suspected internal deletion, this clone was ignored    
CB156105 Liver Gene F2RL1, variant not shown         Submitted on the opposite strand    
NM_005242.4   Gene F2RL1, variant not shown       RefSeq,      
? Gene Summary Gene on genome mRNA Expression Tissue Function, regulation, related genes DI